PLPC VP receives stock, withholds shares for tax

Preformed Line Products VP-Research & Engineering John J. Olenik reported equity compensation transactions dated 02/04/2026.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Preformed Line Products VP-Research & Engineering John J. Olenik reported equity compensation transactions dated 02/04/2026. He acquired 1,160 common shares at $0 upon restricted stock units vesting tied to performance goals, then had 987 shares withheld at $245.42 to cover related taxes.

After these moves, he directly owned 7,506 common shares and 752 common shares indirectly through a 401(k) plan. Olenik was also granted 441 new restricted stock units at $0, which, like his existing 730 and 783-unit awards, convert into common shares on a one-for-one basis and vest three years from the grant date.

Insider Trade Summary

6 transactions reported

Mixed 6 txns

Insider Olenik John J

Role VP-Research & Engineering

Type	Security	Shares	Price	Value
Grant/Award	Restricted stock units	441	$0.00	$0.00
Grant/Award	Common shares, $2 par value	1,160	$0.00	$0.00
Exercise Price or Tax Liability	Common shares, $2 par value	987	$245.42	$242K
holding	Restricted stock units	--	--	--
holding	Restricted stock units	--	--	--
holding	Common shares, $2 par value	--	--	--

Holdings After Transaction: Restricted stock units — 1,954 contracts for 1,513 underlying shares (Direct); Common shares, $2 par value — 7,506 shares (Direct); Common shares, $2 par value — 752 shares (Indirect, by 401(k) plan)

Footnotes (4)

F1. Restricted stock units convert into common stock on a one-for-one basis, based on the achievement of performance goals.
F2. This transaction includes the payment of 457 shares to cover the tax withholding for the vesting that occurred on December 31, 2025 with settlement not occurring until February 4, 2026.
F3. Restricted stock units convert into common stock on a one-for-one basis.
F4. Restricted stock units vest 3 years from the date of grant.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did PLPC executive John J. Olenik report?

John J. Olenik, VP-Research & Engineering at PLPC, reported performance-based restricted stock units vesting into 1,160 common shares at $0 and a 441-unit new RSU grant. He also reported a tax-withholding transaction and updated direct and 401(k) share holdings as of February 4, 2026.

How many PLPC common shares does John J. Olenik own after this Form 4?

Following the reported transactions, John J. Olenik beneficially owned 7,506 PLPC common shares directly and 752 common shares indirectly through a 401(k) plan. These figures reflect both the 1,160-share equity award and the 987-share tax withholding reported for February 4, 2026.

What was the purpose of the 987 PLPC shares reported with code F?

The 987 PLPC common shares reported under transaction code F were withheld at $245.42 per share to cover tax obligations. A footnote explains this includes 457 shares related to vesting on December 31, 2025, with settlement occurring on February 4, 2026.

What restricted stock unit grants does PLPC’s VP-Research & Engineering hold?

On February 4, 2026, John J. Olenik received 441 new restricted stock units that convert into common shares one-for-one. He also continued to hold existing RSU awards of 730 and 783 units, which vest three years from their respective grant dates under the company’s equity program.

How do PLPC restricted stock units held by John J. Olenik convert and vest?

The filing states PLPC restricted stock units convert into common shares on a one-for-one basis. Some units vest based on achievement of performance goals, while a footnote clarifies RSUs generally vest three years from the grant date, after which they settle into common shares.

What role does John J. Olenik hold at Preformed Line Products (PLPC)?

John J. Olenik is identified as an officer of Preformed Line Products with the title VP-Research & Engineering. The Form 4 confirms he is not a director or 10% owner, and the reported transactions reflect his equity compensation and related tax-withholding activity on February 4, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/06/2026 - 05:14 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Olenik John J

(Last)

(First)

(Middle)

660 BETA DRIVE

(Street)

CLEVELAND

44143

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PREFORMED LINE PRODUCTS CO [ PLPC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP-Research & Engineering

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common shares, $2 par value	02/04/2026		A		1,160	A	$0⁽¹⁾	8,493	D
Common shares, $2 par value	02/04/2026		F		987⁽²⁾	D	$245.42	7,506	D
Common shares, $2 par value								752	I	by 401(k) plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted stock units	$0⁽³⁾	02/04/2026		A		441		⁽⁴⁾	⁽⁴⁾	Common shares, $2 par value	441	$0	441	D
Restricted stock units	$0							⁽⁴⁾	⁽⁴⁾	Common shares, $2 par value	730		730	D
Restricted stock units	$0							⁽⁴⁾	⁽⁴⁾	Common shares, $2 par value	783		783	D

Explanation of Responses:

1. Restricted stock units convert into common stock on a one-for-one basis, based on the achievement of performance goals.

2. This transaction includes the payment of 457 shares to cover the tax withholding for the vesting that occurred on December 31, 2025 with settlement not occurring until February 4, 2026.

3. Restricted stock units convert into common stock on a one-for-one basis.

4. Restricted stock units vest 3 years from the date of grant.

Remarks:

	/s/ Caroline S. Vaccariello, by power of attorney	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR